A citation-based method for searching scientific literature

Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson, Niki Arya, Johan Bodegård, Niklas Hammar, Peter Fenici. Circulation 2017
Times Cited: 383



Karin Rådholm, Gemma Figtree, Vlado Perkovic, Scott D Solomon, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Terrance D Barrett, Wayne Shaw, Mehul Desai, David R Matthews, Bruce Neal. Circulation 2018
Times Cited: 170




List of shared articles



Times cited

A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe.
S Seidu, X Cos, S Brunton, S B Harris, S P O Jansson, M Mata-Cases, A M J Neijens, P Topsever, K Khunti. Prim Care Diabetes 2021
4



Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes.
Dalal Y Al-Bazz, John Ph Wilding. Future Cardiol 2020
0


Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2.
Srikanth Yandrapalli, Aaqib Malik, Adam Horblitt, Gayatri Pemmasani, Wilbert S Aronow, William H Frishman. Cardiol Rev 2020
2

Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?
Francesco Giorgino, Jiten Vora, Peter Fenici, Anna Solini. Diabetes Obes Metab 2020
5

Reappraisal on pharmacological and mechanical treatments of heart failure.
Bo Liang, Yu-Xiu Zhao, Xiao-Xiao Zhang, Hui-Ling Liao, Ning Gu. Cardiovasc Diabetol 2020
3


The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study.
Hung-Yi Chen, Jing-Yang Huang, Wun-Zhih Siao, Gwo-Ping Jong. Cardiovasc Diabetol 2020
5

2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
Chern-En Chiang, Kwo-Chang Ueng, Ting-Hsing Chao, Tsung-Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih-Hsien Sung, Hung-I Yeh, Yi-Heng Li, Ping-Yen Liu,[...]. J Chin Med Assoc 2020
0

Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence.
Phil McEwan, Hayley Bennett, Kamlesh Khunti, John Wilding, Christopher Edmonds, Marcus Thuresson, Eric Wittbrodt, Peter Fenici, Mikhail Kosiborod. Diabetes Obes Metab 2020
0


Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure.
Mieczysław Dutka, Rafał Bobiński, Izabela Ulman-Włodarz, Maciej Hajduga, Jan Bujok, Celina Pająk, Michał Ćwiertnia. Heart Fail Rev 2020
0